华仁药业：2025年半年度公司实现营业收入623，896，434.45元

Core Insights - Huaren Pharmaceutical reported a revenue of 623,896,434.45 yuan for the first half of 2025, representing a year-on-year decline of 19.13% [2] - The net profit attributable to shareholders of the listed company was 37,332,883.17 yuan, down 49.01% year-on-year [2] Financial Performance - Revenue for the first half of 2025: 623.90 million yuan, down 19.13% compared to the previous year [2] - Net profit for the same period: 37.33 million yuan, a decrease of 49.01% year-on-year [2]